{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Patient {{$iPatientNo}}

DEMOGRAPHIC DATA

@if(isset(session()->get('doctor')['vCentralCode']))
@else
@endif
Since: Years / Months
Sr. No Test Observations *

1

PSA

ng /ml

2

Gleason Score

Was the patient on previous treatment with Abiraterone acetate?*

Was the patient previously treated with Docetaxel therapy?*

Which of the following treatment you prefer for oligometastatic prostate cancer?*

All eligible patients of metastatic castration-sensitive prostate cancer should be offered treatment intensification upfront (ADT + A choice of agent from docetaxel, abiraterone, apalutamide, enzalutamide)*

Treatment prescribed *

Name of Drug Dose Frequency Duration

What is the reason for changing to current treatment? (Please tick the appropriate options below.)*

Physician’s Assessment at End of Treatment

Physician effectiveness assessment*

Physician tolerability assessment*

Which of the following sequence do you follow in your clinical practice for the treatment of mCRPC whose disease has progressed on first line ADT.*